Due to the vulnerable points of CA125 as a biomarker of ovarian cancer [23], combining one or more other tumor markers with CA125 might improve the sensitivity and specificity of the diagnosis of ovarian cancers or the earlier detection of such cancers [9]. This evidence concerns the gene MUC16 and ovarian carcinoma.